Valneva reports long-lasting antibody persistence in its chikungunya vaccine three years post-dose, supporting its global ...

Company Expects to Announce VAX-31 Infant Study Topline Safety, Tolerability and Immunogenicity Data from Primary Immunization Series in ...

Learn what virus specialists recommend as you head out for your seasonal vaccinations: "This is a small price to pay for ...